Corrigendum to "First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer IMpassion130 final overall survival analysis": Annals of Oncology 2021; 32: 983-993
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2 November 2021
|
| In: |
Annals of oncology
Year: 2021, Volume: 32, Issue: 12, Pages: 1650 |
| ISSN: | 1569-8041 |
| DOI: | 10.1016/j.annonc.2021.10.002 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.annonc.2021.10.002 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753421045208 |
| Author Notes: | L.A. Emens, S. Adams, C.H. Barrios, V. Diéras, H. Iwata, S. Loi, H.S. Rugo, A. Schneeweiss, E.P. Winer, S. Patel, V. Henschel, A. Swat, M. Kaul, L. Molinero, S. Patel, S.Y. Chui & P. Schmid |
| Item Description: | Gesehen am 03.02.2022 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1569-8041 |
| DOI: | 10.1016/j.annonc.2021.10.002 |